Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback
- PMID: 27207626
- PMCID: PMC4885441
- DOI: 10.1136/bmjopen-2015-010865
Optimising the changing role of the community pharmacist: a randomised trial of the impact of audit and feedback
Abstract
Objective: To evaluate the impact of comparative performance feedback to community pharmacists on provision of professional services and the quality of patients' medication use.
Design: Randomised, controlled, single-blind trial.
Setting: All 1833 community pharmacies in the Quebec province, Canada.
Participants: 1814 pharmacies not opting out and with more than 5 dispensings of the target medications during the 6-month baseline were randomised by a 2×2 factorial design to feedback first for hypertension adherence (907 control, 907 intervention) followed by randomisation for asthma adherence (791 control, 807 intervention). 1422 of 1814 pharmacies had complete information available during the follow-up for hypertension intervention (706 intervention, 716 control), and 1301 of 1598 had the follow-up information for asthma (657 intervention, 644 control).
Intervention: Using provincial billing data to measure performance, mailed comparative feedback reported the pharmacy-level percentage of dispensings to patients non-adherent to antihypertensive medications or overusing asthma rescue inhalers.
Primary and secondary outcome measures: The number of hypertension/asthma services billed per pharmacy and percentage of dispensings to non-adherent patients over the 12 months post intervention.
Results: Feedback on the asthma measure led to increased provision of asthma services (control 0.2, intervention 0.4, RR 1.58, 95% CI 1.02 to 2.46). However, this did not translate into reductions in patients' overuse of rescue inhalers (control 45.5%, intervention 44.6%, RR 0.99, 95% CI 0.98 to 1.01). For non-adherence to antihypertensive medications, feedback resulted in no difference in either provision of hypertension services (control 0.7, intervention 0.8, RR 1.25, 95% CI 0.86 to 1.82) or antihypertensive treatment adherence (control 27.9%, intervention 28.0%, RR 1.0, 95% CI 0.99 to 1.00). Baseline performance did not influence results, and there was no evidence of a cumulative effect with repeated feedback.
Conclusions: Comparative pharmacy performance feedback increased the provision of asthma pharmacists' services but did not improve the performance on medication-use measures. Billing data can be used to evaluate the impact of billable services rendered by pharmacists on the quality of patients' medication use.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures
Similar articles
-
Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.BMJ Open. 2017 Sep 21;7(9):e015877. doi: 10.1136/bmjopen-2017-015877. BMJ Open. 2017. PMID: 28939571 Free PMC article.
-
The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.Trials. 2017 Jan 19;18(1):29. doi: 10.1186/s13063-016-1696-3. Trials. 2017. PMID: 28103948 Free PMC article. Clinical Trial.
-
Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study.Res Social Adm Pharm. 2013 Nov-Dec;9(6):797-805. doi: 10.1016/j.sapharm.2012.12.006. Epub 2013 Feb 4. Res Social Adm Pharm. 2013. PMID: 23391845 Clinical Trial.
-
Impact of educational intervention by community pharmacists on asthma clinical outcomes, quality of life and medication adherence: A systematic review and meta-analysis.J Clin Pharm Ther. 2021 Oct;46(5):1254-1262. doi: 10.1111/jcpt.13419. Epub 2021 Apr 5. J Clin Pharm Ther. 2021. PMID: 33817821
-
The effect of partial patients' adherence to antihypertensive drugs: scope for pharmacists' role in hypertension care.Int J Clin Pharm. 2018 Feb;40(1):1-2. doi: 10.1007/s11096-017-0557-9. Int J Clin Pharm. 2018. PMID: 29116462 Review.
Cited by
-
Audit and feedback in community pharmacy: An untapped strategy of quality improvement.Can Pharm J (Ott). 2021 Nov 5;155(2):79-81. doi: 10.1177/17151635211056528. eCollection 2022 Mar-Apr. Can Pharm J (Ott). 2021. PMID: 35300026 Free PMC article. No abstract available.
-
Professional pharmacy Services' outcomes performance measurement: A narrative review.Explor Res Clin Soc Pharm. 2024 Oct 23;16:100533. doi: 10.1016/j.rcsop.2024.100533. eCollection 2024 Dec. Explor Res Clin Soc Pharm. 2024. PMID: 39555325 Free PMC article. Review.
-
Determinants of community pharmacists' quality of care: a population-based cohort study using pharmacy administrative claims data.BMJ Open. 2017 Sep 21;7(9):e015877. doi: 10.1136/bmjopen-2017-015877. BMJ Open. 2017. PMID: 28939571 Free PMC article.
-
Sustainability, spread, and scale in trials using audit and feedback: a theory-informed, secondary analysis of a systematic review.Implement Sci. 2023 Oct 26;18(1):54. doi: 10.1186/s13012-023-01312-0. Implement Sci. 2023. PMID: 37885018 Free PMC article.
-
Audit and feedback: effects on professional practice.Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD000259. doi: 10.1002/14651858.CD000259.pub4. Cochrane Database Syst Rev. 2025. PMID: 40130784
References
-
- Academy of Managed Care Pharmacy, American Pharmacists Association, Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality. J Am Pharm Assoc 2014;54:228–40. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical